Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News Central Australia.
Press releases published on July 1, 2025
dion seminara architecture Helps Brisbane Homeowners Future-Proof Their Homes with Flexible Design Strategies
EIN Presswire
·
July 1, 2025
dion seminara architecture highlights how adaptable design strategies can help Brisbane homeowners prepare their homes for evolving lifestyle needs. BRISBANE, QUEENSLAND, AUSTRALIA, July 1, 2025 /EINPresswire.com/ -- dion seminara architecture is …
IREN Appoints Anthony Lewis as Chief Capital Officer to Lead Capital Markets Strategy
GlobeNewswire
·
July 1, 2025
SYDNEY, July 01, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) today announced the appointment of Anthony Lewis as Chief Capital Officer, a newly established role responsible for overseeing the Company’s capital markets activity. Mr. Lewis will lead …
Onefxclub net Equips Users With Advanced Analysis Tools
GlobeNewswire
·
July 1, 2025
LAUNCESTON, Australia, July 01, 2025 (GLOBE NEWSWIRE) -- Onefxclub.net, a company specializing in financial services, has expanded its offering by providing users with advanced tools designed to assist in making informed decisions based on comprehensive …
Commencement of Chief Executive Officer
GlobeNewswire
·
July 1, 2025
PERTH, Australia, July 01, 2025 (GLOBE NEWSWIRE) -- Canyon Resources Limited (ASX: CAY) (‘Canyon’ or the ‘Company’) is pleased to announce that Mr Peter Secker has officially commenced his role as Chief Executive Officer (CEO), effective 1 July 2025. …
Locksley Resources Limited (LKY.AX) El Campo REE Project Drilling on Schedule and Fully Approved
ABN Newswire
·
July 1, 2025
Sydney, July 1, 2025 AEST (ABN Newswire) - Locksley Resources Limited (ASX:LKY) (LKYRF:OTCMKTS) is pleased to provide the following update regarding its El Campo rare earths prospect, located within the Mojave Project in San Bernardino County, California. …
Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure
GlobeNewswire
·
July 1, 2025
NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items required …